Comprehensive bioinformatics analyses have revealed that adherent or semi-adherent SCLC cells exhibit increased activity of the PI3K/Akt/mTOR pathway and show significant resistance to chemotherapy [108]. The gene discussed is MTOR; the disease is small cell lung carcinoma.